PEGylated liposomal photosensitizers as theranostic agents for dual-modal photoacoustic and fluorescence imaging-guided photodynamic therapy

Hao Xu; Yubin Liu; Junle Qu; Zhen Yuan

doi:10.1142/s1793545819410037

[1] J. P. Celli et al., “Imaging and photodynamic therapy: Mechanisms, monitoring, and optimization," Chem. Rev. 110, 2795–2838 (2010).

[2] A. B. E. Attia et al., “Phthalocyanine photosensitizers as contrast agents for in vivo photoacoustic tumor imaging," Biomed. Opt. Exp. 6, 591–598 (2015).

[3] T. Hasan et al., “Photodynamic therapy of Cancer," Holland-Frei Cancer Medicine D. W. Kufe et al. Eds., pp. 605–622 B.C. Decker, (2003).

[4] J. Zhang et al., “A PIID-DTBT based semiconducting polymer dots with broad and strong optical absorption in the visible-light region: Highly effective contrast agents for multiscale and multispectral photoacoustic imaging," Nano Res. 10, 64–76 (2017).

[5] J. Cheon, J. H. Lee, “Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology," Acc. Chem. Res. 41, 1630–1640 (2008).

[6] D. Kumar, L. Shan, Y. Zhang, “Nanoparticles in photodynamic therapy: An emerging paradigm," Adv. Drug Deliv. Rev. 60, 1627–1637 (2008).

[7] S. Lucky et al., “Nanoparticles in photodynamic therapy," Chem. Rev. 115, 1990–2042 (2015).

[8] G. Obaid et al., “Photonanomedicine: A convergence of photodynamic therapy and nanotechnology," Nanoscale 8, 12471–12503 (2016).

[9] H. Kobayashi et al., “Improving conventional enhanced permeability and retention (EPR) effects; What is the appropriate target " Theranostics 4, 81–89 (2014).

[10] Y. Liu, H. Jiang, Z. Yuan, “Two schemes for quantitative photoacoustic tomography based on Monte Carlo simulation," Med. Phys. 43, 3987–3997 (2016).

[11] D. Gao et al., “Protein-modiˉed CuS nanotriangles: A potential multimodal nanoplatform for in vivo tumor photoacoustic/magnetic resonance dual-modal imaging," Adv. Health. Mater. 6, (2017).

[12] H. Tominaga et al., “A water-soluble tetrazolium salt useful for colorimetric cell viability assay," Anal. Commun. 36, 47–50 (1999).

[13] J. Zhang et al., “Development of a multi-band photoacoustic tomography imaging system based on a capacitive micromachined ultrasonic transducer array," Appl. Opt. 56, 4012–4018 (2017).

[14] D. Y. Gao et al., “Engineering a protein-based nanoplatform as an antibacterial agent for light activated dual-modal photothermal and photodynamic therapy of infection in both the NIR i and II windows," J. Mater. Chem. B 6, 732–739 (2018).

[15] S. Vemuri et al., “Preparation and characterization of liposomes as therapeutic delivery systems: A review," Pharm. Acta Helv. 70, 95–111 (1995).

[16] M. F. Oliveira et al., “Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market," J. Chem. Biol. 6, 7–23 (2013).

[17] A. S. L. Derycke et al., “Liposomes for photodynamic therapy," Adv. Drug Deliv. Rev. 56, 17–30 (2004).

[18] H. Maeda, “Macromolecular therapeutics in cancer treatment: The EPR effect and beyond," J. Control. Release 164, 138–144 (2012).

[19] A. M. Richter et al., “Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model," Br. J. Cancer 63, 87–93 (1991).